NCT03488199View on ClinicalTrials.gov

The SIBERIA Trial (Acculink™ Versus CGuard™)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

February 11, 2021

Study Completion Date

March 9, 2021

Conditions
Patients With Aterosclerotic Carotid StenosisSymptomatic Patients (Stenosis > 50%)Asymptomatic Patients (Stenosis ≥80%)
Interventions
DEVICE

Stent Acculink ™

Carotid Artery Revascularization using Stents

DEVICE

CGuardTM™

Carotid Artery Revascularization using Stents

Trial Locations (1)

Unknown

Andrey A. Karpenko, Novosibirsk

All Listed Sponsors
lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT03488199 - The SIBERIA Trial (Acculink™ Versus CGuard™) | Biotech Hunter | Biotech Hunter